Results 11 to 20 of about 9,019,898 (255)
Optimal Controls of the Highly Active Antiretroviral Therapy [PDF]
In this paper, we study generic properties of the optimal, in a certain sense, highly active antiretroviral therapy (or HAART). To address this problem, we consider a control model based on the 3-dimensional Nowak–May within-host HIV dynamics model ...
Ellina V. Grigorieva +2 more
doaj +4 more sources
Highly active antiretroviral therapy [PDF]
Cardiovascular risk needs to be assessed before starting treatment I n the industrialised world the availability of highly active antiretroviral treatment (HAART) for advanced HIV-1 disease has dramatically improved patients' life expectancy.1 However, an unfailing lifelong commitment to antiviral drugs is expected.
Filip, Moerman +3 more
openaire +4 more sources
Highly active antiretroviral therapy [PDF]
The barriers to providing highly active antiretroviral therapy (HAART) in poor countries have until recently seemed insurmountable. The cited problems have ranged from weak health systems and poor infrastructure to inadequate numbers of health professionals. In reality, the main barrier has been the very high cost of antiretroviral drugs.
openaire +2 more sources
Highly Active Antiretroviral Therapy and the Kidney [PDF]
Highly active antiretroviral therapy has dramatically altered the treatment and life expectancy of individuals who are infected with HIV. More than 20 antiretroviral drugs and drug combinations now are available in the United States. Nephrologists need to have an understanding of the pharmacokinetics of antiretroviral medications and the proper dosing ...
Jeffrey S, Berns, Nishaminy, Kasbekar
openaire +2 more sources
Evaluation of Adherence to Highly Active Antiretroviral Therapy
The efficacy of highly active antiretroviral therapy (HAART) with regard to the morbidity and mortality of patients infected with human immunodeficiency virus (HIV) is well known. Nevertheless, this efficacy is affected at both the individual and population levels when compliance with the treatment is inadequate.1,2 Improper adherence to HAART has been
Martín Fernández, Jesús +3 more
openaire +3 more sources
Nutrition in the Era of Highly Active Antiretroviral Therapy [PDF]
Despite tremendous advances in treatment, persons with human immunodeficiency virus (HIV) infection commonly experience a variety of nutritional problems, such as weight loss, fat redistribution, and obesity. We discuss basic dietary and metabolic problems as they pertain to persons with HIV infection and provide practical suggestions for their ...
A H, Shevitz, T A, Knox
openaire +2 more sources
Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy [PDF]
Background: Patients with human immunodeficiency virus (HIV) infection and a history of Pneumocystis carinii pneumonia are at high risk for relapse if they are not given secondary prophylaxis. Whether secondary prophylaxis against P.
H. Furrer +45 more
core +1 more source
Daily Dosing of Highly Active Antiretroviral Therapy [PDF]
Complex treatment schedules for human immunodeficiency virus (HIV) disease, which can have a high pill burden and can include multiple daily doses, in addition to the adverse effects that the medications can cause, may reduce patient adherence to therapy. Reduced adherence prevents achievement of the desired goal of full suppression of HIV replication,
Keith A, Rosenbach +2 more
openaire +2 more sources
Highly Active Antiretroviral Therapy (HAART) [PDF]
No Abstract. Journal of Ethiopian Medical Journal Vol. 3(2) 2002: pp.
Daniel Thomas Ginat +1 more
openaire +3 more sources
HAART (Highly Active Anti-Retroviral Therapy) : An overview
Highly Active Anti - Retroviral Therapy (HAART) is a triple combination of ART drugs and is a n effective tool to control disease progression in HIV disease.
Praful Pande, Vivek Hande
doaj +1 more source

